Shendelman Shoshana 4
4 · Applied Therapeutics Inc. · Filed Dec 1, 2023
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2023-11-30$1.97/sh−3,968$7,817→ 2,596,387 total
Holdings
- 88,397(indirect: See footnote)
Common Stock
- 1,750,000(indirect: See footnote)
Common Stock
- 709,720(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
- 1,492,094(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Through a grantor retained annuity trust.
- [F3]Through a family trust controlled by the reporting person's spouse.
- [F4]Through the reporting person's spouse.
- [F5]Through a family trust controlled by the reporting person.
- [F6]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.